Show simple item record

dc.contributor.authorMILLS, KINGSTON
dc.date.accessioned2009-09-28T18:38:53Z
dc.date.available2009-09-28T18:38:53Z
dc.date.issued1998
dc.date.submitted1998en
dc.identifier.citationMills, K.H.G., Ryan, M., Ryan, E. and Mahon, B. P. `A murine model in which protection correlates with pertussis vaccine efficacy in children demonstrates complementary roles for humoral and cell mediated immunity in protection against Bordetella pertussis? in Infection and Immunity, 66, (2), 1998, pp 594 - 602en
dc.identifier.otherY
dc.identifier.otherYen
dc.descriptionPUBLISHEDen
dc.description.abstractThe results of phase 3 efficacy trials have shown that acellular and whole-cell pertussis vaccines can confer protection against whooping cough. However, despite the advances in vaccine development, clinical trials have not provided significant new information on the mechanism of protective immunity against Bordetella pertussis. Classical approaches based on measurement of antibody responses to individual antigens failed to define an immunological correlate of protection. A reliable animal model, predictive of acellular and whole-cell pertussis vaccine potency in children, would facilitate an elucidation of the mechanism of immune protection against B. pertussis and would assist in the regulatory control and future development of pertussis vaccines. In this study, we have shown that the rate of B. pertussis clearance following respiratory challenge of immunized mice correlated with vaccine efficacy in children. Using this model together with mice with targeted disruptions of the gamma interferon (IFN-?) receptor, interleukin-4 or immunoglobulin heavy-chain genes, we have demonstrated an absolute requirement for B cells or their products in bacterial clearance and a role for IFN-? in immunity generated by previous infection or immunization with the whole-cell pertussis vaccine. The results of passive immunization experiments suggested that protection early after immunization with acellular pertussis vaccines is mediated by antibody against multiple protective antigens. In contrast, more complete protection conferred by previous infection or immunization with whole-cell pertussis vaccines reflected the induction of Th1 cells. Our findings suggest that the mechanism of immunity against B. pertussis involves humoral and cellular immune responses which are not directed against a single protective antigen and thus provide an explanation for previous failures to define an immunological correlate of protection.en
dc.description.sponsorshipThis work was supported by grant 039583 from The Wellcome Trust. Mark Ryan is supported by a grant from The Health Research Board of Ireland.en
dc.format.extent594en
dc.format.extent602en
dc.format.extent209579 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.publisherAmerican Society for Microbiologyen
dc.relation.ispartofseriesInfection and Immunityen
dc.relation.ispartofseries66en
dc.relation.ispartofseries2en
dc.rightsYen
dc.subjectBiochemistryen
dc.titleA murine model in which protection correlates with pertussis vaccine efficacy in children demonstrates complementary roles for humoral and cell mediated immunity in protection against Bordetella pertussisen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/millsk
dc.identifier.rssinternalid7723
dc.contributor.sponsorHealth Research Board
dc.contributor.sponsorWellcome Trust
dc.identifier.urihttp://hdl.handle.net/2262/33375


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record